SFRP5 and fatty liver disease: Experimental evidence from murine disease models and studies on SFRP5 knockout mice suggests that secretion of SFRP5 by adipocytes prevents hepatic steatosis and metabolic dysfunction associated with liver fibrosis by modulating inflammatory cells within adipose tissue.12, 14